Using aromatherapy and hypnosis to help cancer patients during medical procedures
Evaluation of the Therapeutic Approach of Aromatherapy by Olfaction of Essential Oils in Association With Hypnosis in the Care of Patients Followed in Oncology for Cancer Within a Mobile Palliative Care Support Team (EMASP)
This study is testing whether combining aromatherapy with hypnosis can help cancer patients feel less anxious and more comfortable during medical procedures like blood tests and dressing changes.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 66 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Centre Hospitalier Intercommunal Creteil Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Créteil) |
| Trial ID | NCT05714995 on ClinicalTrials.gov |
What this trial studies
This observational study aims to evaluate the effectiveness of combining aromatherapy with hypnosis to manage anxiety and improve comfort in cancer patients undergoing medical procedures such as blood tests and dressing changes. Patients will be assessed for anxiety and well-being before and after these procedures, with randomization occurring prior to the first hypnosis session. The study will track patient comfort levels and overall experience during these potentially distressing interventions.
Who should consider this trial
Good fit: Ideal candidates include adults aged 18 and older who are undergoing treatment for cancer and require specific medical procedures.
Not a fit: Patients with cognitive disorders, those unable to provide consent, or individuals with allergies to essential oils may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly reduce anxiety and discomfort for cancer patients during medical procedures.
How similar studies have performed: While the combination of hypnosis and aromatherapy is not widely tested, similar studies have shown promising results in reducing anxiety in patients undergoing various medical procedures.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients aged ≥18 years * Patients followed in medical oncology and by the mobile palliative care support team * From the first line of chemotherapy * Patient requiring one of the following procedures: * Blood samples via a central catheter with a percutaneous implantable chamber, with a Huber needle * Peripheral venous samples * Change of dressing for cancerous lesion * Complete toilet in bed * Patients who have given their consent * Patient affiliated with a social security scheme Exclusion Criteria: * Protected person under guardianship or curatorship, * Person deprived of liberty * Person unable to express consent * Pregnant woman and breastfeeding woman * History of allergy or intolerance to essential oils * Patients with cognitive or language disorders that make it impossible to answer the questionnaires * Psychotic disorders
Where this trial is running
Créteil
- Centre Hospitalier Intercommunal de Créteil — Créteil, France (Recruiting)
Study contacts
- Study coordinator: Lambert VADROT
- Email: lambert.vadrot@chicreteil.fr
- Phone: 0157022675
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.